Pathologic Response During Chemo-radiotherapy and Variation of Serum VEGF Levels Could Predict Effects of Chemo-Radiotherapy in Patients with Esophageal Cancer

Yu, Jing-Ping; Lu, Wen-Bin; Wang, Jian-Lin; Ni, Xin-Chu; Wang, Jian; Sun, Zhi-Qiang; Sun, Su-Ping

추천

검색

자료유형: 학술저널

저자정보: Yu, Jing-Ping (Department of Radiation Oncology, Changzhou NO.2 People's Hospital) Lu, Wen-Bin (Department of Radiation Oncology, Changzhou NO.2 People's Hospital) Wang, Jian-Lin (Department of Radiation Oncology, Changzhou NO.2 People's Hospital) Ni, Xin-Chu (Department of Radiation Oncology, Changzhou NO.2 People's Hospital) Wang, Jian (Department of Radiation Oncology, Changzhou NO.2 People's Hospital) Sun, Zhi-Qiang (Department of Radiation Oncology, Changzhou NO.2 People's Hospital) Sun, Su-Ping (Department of Radiation Oncology, Changzhou NO.2 People's Hospital)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제16권 제3호

발행연도: 2015.1

수록면: 1,111 - 1,116 (6page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: To investigate the relationship between pathologic tumor response to concurrent chemoradiotherapy and variation of serum VEGF in patients with esophageal cancer. Materials and Methods: Forty six patients with esophageal cancer who were treated with concurrent chemo-radiotherapy were enrolled. Endoscopic and pathologic examination was conducted before and four weeks afterwards. Serum level of VEGF was documented before, four weeks later and after chemo-radiotherapy. The relationship between pathologic response and the variation of serum level of VEGF and its influence on the prognosis were investigated. Results: Serum level of VEGF decreased remarkably during and after chemo-radiotherapy in patients whose pathologic response was severe (F=5.393, 4.587, P(0.05). There were no statistical differences of serum VEGF level before, during and after chemo-radiotherapy for patients whose pathologic response was moderate or mild. There were 18 (85.7%), 7 (53.8%) and 6 patients (50.0%) whose serum VEGF level dropped in the severe, moderate and mild group, respectively, with significant differences among these groups (p=0.046). Two year survival rates of patients with severe, moderate and mild pathologic response were 61.9%, 53.8% and 33.3% respectively, and no statistically difference between severe and mild group regarding OS (p=0.245) was tested. Conclusions: Tumor pathologic response during chemo-radiotherapy and the changes of serum VEGF lever could predict curative effects of chemo-radiotherapy in patients with esophageal cancer.

#Esophageal carcinoma #pathology response #vascular endothelial growth factor #prognosis

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!